1-octyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide

We are 1-octyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide CAS:862731-66-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


English Name: 1-octyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide
Synonyms:3-Methyl-1-octyl-1H-imidazol-3-ium bis(trifluoroacetyl)azanide
Molecular Formula: C14H23F6N3O4S2
Molecular Weight: 475.47
CAS No.: 862731-66-6
Purity: 99%
 
Technical Information

Appearance:	Purity:
NMR: Passed	null
Solubility:	Insolubility:
Impurity content: (1) Methylimidazole content: < 1000 ppm; (2) Halogen content: < 1000 ppm; (3) Water content: < 1000 ppm

 
Physics-Chemistry Properties

Melting point: -84℃（Tg）	Decomposition temperature:
Conductivity: 1.3mS/cm	Electrochemical window:
Viscosity: 93cp	Density: 1.317g/cm3

 
Our company has been engaged in the R&D, production of ionic liquids and related technologies for more than ten years. Since 2007, our company has supplied ionic liquid reagents to customers, and can provide customers with ionic liquid products from grams to hundreds of tons. The main product series are: Imidazolium ionic liquids, single-substituted Im ionic liquids, Disubstituted Im ionic liquids, Tri-Substituted Im ionic liquids, Pyrilidinium ionic liquids, Ammonium ionic liquids, Phosphonium ionic liquids, Pyrrolidinium ionic liquids, Piperidinium ionic liquids, Functionized ionic liquids, Vinyl-Based ionic liquids, Hydroxyl-Based ionic liquids, Ether-Based ionic liquids, Ester-Based ionic liquids, Carboxyl-Based ionic liquids, Nitrile-Based ionic liquids, Amido-Based ionic liquids, SulfoAcid-Based ionic liquids, Benzyl-Based ionic liquids, Guanidine-Based ionic liquids, Oxonium salts



Related News: As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials.2-Bromo-6-fluorobenzoic acid As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials.2 – [(1R) -3- (Diisopropilamino) -1-fenilpropil] -4- (hidroximetil) fenol (2E) -2-butenodioato (1: 1) CAS:380636-50-0 The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China’s public hospitals, where most Chinese people buy their drugs.3-chloro-4-[(3-fluorophenyl)methoxy]aniline In addition to APIs, a variety of pharmaceutical excipients are contained in the medicine.In addition to APIs, a variety of pharmaceutical excipients are contained in the medicine.